Co-operation of α-galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model
Keyword(s):
This is the first demonstration that α-galactosylceramide (α-Galcer)-loaded tumour cells (tumour–Gal) plus the Toll-like receptor 9 (TLR9) agonist as therapeutic anti-cancer vaccination. This strategy may have broad applicability and lead to development of effective immunotherapy against various human cancers.
Keyword(s):
1994 ◽
Vol 47
(3)
◽
pp. 215-223
Keyword(s):
2010 ◽
Vol 101
(11)
◽
pp. 2325-2332
◽
Keyword(s):
2015 ◽
Vol 199
(1)
◽
pp. 106-114
◽
2019 ◽
2021 ◽
Keyword(s):
2007 ◽
Vol 142
(2)
◽
pp. 320-326
◽